SRPT Shares Outstanding History



Below is a table of the SRPT shares outstanding history going back to 7/12/2012:

Date SRPT Shares Outstanding
7/12/20120.02B
7/31/201222.62M
10/31/201225.45M
2/28/201331.83M
4/30/201331.91M
7/31/201333.53M
10/31/201337.58M
2/24/201437.78M
4/30/201440.68M
7/31/201440.92M
10/31/201441.31M
2/23/201541.31M
4/30/201541.47M
7/31/201541.51M
10/30/201545.27M
2/19/201645.67M
3/31/201645.77M
4/29/201645.77M
8/3/201647.90M
11/3/201654.59M
2/21/201754.81M
4/28/201754.96M
7/28/201764.33M
10/26/201764.63M
2/23/201864.98M
4/30/201865.53M
8/3/201866.44M
10/26/201866.82M
2/22/201971.29M
5/3/201974.15M
8/2/201974.34M
11/4/201974.54M
2/21/202077.78M
5/1/202077.99M
7/31/202078.51M
10/30/202078.91M
2/19/202179.42M
4/30/202179.77M
7/30/202179.84M
10/29/202187.08M
2/24/202287.15M
4/29/202287.50M
7/29/202287.57M
10/28/202287.78M
2/23/202387.98M
10/27/202393.55M
2/23/202493.86M
4/26/202494.52M
8/2/202495.37M

Also see: SRPT Market Cap History
SRPT YTD Return
SRPT Historical Shares Outstanding:
+12.66% CAGR
SRPT Historical Shares Outstanding: +12.66% CAGR

Mouse over chart for data details
7/12/2012 ...8/2/2024
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. Co. is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It has developed multiple approved products for the treatment of Duchenne muscular dystrophy (Duchenne) and is developing potential therapeutic candidates for a range of diseases and disorders, including Duchenne, Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders. We show 49 historical shares outstanding datapoints in our coverage of SRPT's shares outstanding history.

Understanding the changing numbers of SRPT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SRPT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SRPT by allowing them to research SRPT shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree SRPT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Sarepta Therapeutics (SRPT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

SRRA Shares Outstanding History
SRRK Shares Outstanding History
SRTS Shares Outstanding History
SRZN Shares Outstanding History
SSKN Shares Outstanding History
STAA Shares Outstanding History
STAB Shares Outstanding History
STE Shares Outstanding History
STIM Shares Outstanding History
STML Shares Outstanding History
More Healthcare companies »

 

SRPT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.